Stocks · Healthcare · Medical - Devices
TransMedics Group, Inc. TMDX
$79.80 +1.48% Close, Oct 2, 2026 · NASDAQ · Market cap $2.76B
Strong growthWeak trendInexpensive vs sector
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $3.86, up 100.0% year over year.
- At 20.7× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Net debt is 3.3× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 27%
- EPS growth (TTM, YoY)Top 14%
- FCF growth (TTM, YoY)Top 4%
- Revenue growth, 3-year CAGRTop 9%
- Revenue growth accelerationBottom 28%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 23%
- Gross marginBottom 45%
- Operating marginTop 22%
- Cash conversion (OCF / net income)Bottom 21%
- Accruals (lower is better)Bottom 16%
- Net debt / EBITDA (lower is better)Bottom 27%
- Interest coverTop 29%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 10%
- Free-cash-flow yieldTop 27%
- EBITDA / enterprise valueTop 28%
- Sales / enterprise valueBottom 49%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 19%
- 6-month returnBottom 24%
- 1-year return vs S&P 500Bottom 21%
- Distance from 52-week highBottom 30%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 32%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 38%
- Upside to consensus price targetBottom 27%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 32%
- Maximum drawdown, 3 yearsTop 47%
- Beta vs S&P 500 (lower is better)Top 46%
- Net debt / EBITDA (lower is better)Bottom 27%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 30.2% | 25.8% | ↓ |
| EPS growth (YoY) | 221.3% | 100.0% | ↓ |
| Gross margin | 59.8% | 58.7% | ↓ |
| Operating margin | 14.4% | 12.2% | ↓ |
| FCF margin | 3.3% | 11.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 25.8% | 30.2% | ↓ | Top 27% |
| EPS growth (TTM, YoY) | 100.0% | 221.3% | ↓ | Top 14% |
| Gross margin | 58.7% | 59.8% | ↓ | Bottom 45% |
| Operating margin | 12.2% | 14.4% | ↓ | Top 22% |
| Net margin | 22.7% | 13.5% | ↑ | — |
| Free-cash-flow margin | 11.8% | 3.3% | ↑ | — |
| Return on invested capital | 5.9% | — | Top 23% | |
| Revenue growth, 3-year CAGR | 86.4% | — | Top 9% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 0.96×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 0.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 5.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -26.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.29×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.43%
- Shareholder yield
- -0.43%
- Share count change, 1 year
- +0.4%
- Share count change, 3-year CAGR
- +7.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +13.6%
- Average 2-day reaction, last 8
- +0.2%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $96.86
- Target vs current price
- +21.4%
- Analysts with a rating
- 13
- Share rating Buy or Strong Buy
- 69%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -11.2% | -1.0% | +8.4% | +4.1% | — |
| May 5, 2026 | -51.6% | -2.2% | -33.8% | -29.5% | -21.6% |
| Feb 24, 2026 | +39.0% | +2.3% | +9.2% | -16.8% | -50.9% |
| Oct 29, 2025 | +78.4% | +3.6% | -5.8% | +12.6% | +7.4% |
| Jul 30, 2025 | +91.7% | +2.7% | +19.9% | +9.9% | +14.0% |
| May 8, 2025 | +141.4% | -2.7% | +27.7% | +41.5% | +34.1% |
| Feb 27, 2025 | -13.6% | -2.2% | -8.6% | -4.7% | +67.2% |
| Oct 28, 2024 | -58.6% | +0.9% | -34.2% | -39.3% | -51.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.44 | $0.50 | -11.2% | $189.9M |
| May 5, 2026 | $0.30 | $0.62 | -51.6% | $173.9M |
| Feb 24, 2026 | $0.57 | $0.41 | +39.0% | $160.8M |
| Oct 29, 2025 | $0.66 | $0.37 | +78.4% | $143.8M |
| Jul 30, 2025 | $0.92 | $0.48 | +91.7% | $157.4M |
| May 8, 2025 | $0.70 | $0.29 | +141.4% | $143.5M |
| Feb 27, 2025 | $0.19 | $0.22 | -13.6% | $121.6M |
| Oct 28, 2024 | $0.12 | $0.29 | -58.6% | $108.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 20.7× | 55.8× | 0th | Top 10% |
| P/E (forward) | 54.4× | — | — | — |
| EV / EBITDA | 26.3× | — | — | Top 28% |
| EV / Sales | 4.72× | — | — | Bottom 49% |
| Free-cash-flow yield | 2.87% | — | — | Top 27% |
| Earnings yield | 4.84% | — | — | Top 10% |
P/E over the past five years
Range 20.9× – 94.2× since Sep 30, 2024. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -30.5%
- Earnings per share growth (TTM)
- +100.0%
- Change in P/E multiple
- -62.5%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +6.7%
- 200-day average slope (20 days)
- -4.7%
- Distance from 50-day average
- -6.4%
- Distance from 200-day average
- -20.2%
- RSI (14)
- 39.9
- Relative volume
- 1.71×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 46.0%
- Volatility vs own 5-year history
- 5th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.03
- Correlation with S&P 500
- 0.23
- Current drawdown from 1-year high
- -46.9%
- Maximum drawdown, 3 years
- -67.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 22, 2021 | Feb 23, 2022 | -73.7% | 234 days | 113 days (Aug 5, 2022) |
| Aug 27, 2024 | Jan 21, 2025 | -67.8% | 99 days | Not yet recovered |
| Jul 18, 2023 | Oct 30, 2023 | -61.8% | 73 days | 124 days (Apr 29, 2024) |
| Sep 12, 2022 | Oct 14, 2022 | -29.9% | 24 days | 15 days (Nov 4, 2022) |
| Apr 21, 2023 | May 26, 2023 | -20.3% | 25 days | 30 days (Jul 12, 2023) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.76B
- P/E (TTM)
- 20.7
- EPS, diluted (TTM)
- $3.86
- Revenue (TTM)
- $668.5M
- 52-week range
- $60.11 – $156.00
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $30.3M | $93.5M | $241.6M | $441.5M | $605.5M |
| Gross profit | $21.2M | $65.3M | $154.1M | $262.1M | $362.8M |
| Operating income | -$39.4M | -$31.4M | -$28.7M | $37.5M | $108.6M |
| Net income | -$44.2M | -$36.2M | -$25.0M | $35.5M | $190.3M |
| EPS (diluted) | -$1.60 | -$1.23 | -$0.77 | $1.01 | $4.87 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $108.8M | $121.6M | $143.5M | $157.4M | $143.8M | $160.8M | $173.9M | $189.9M |
| Net income | $4.2M | $6.9M | $25.7M | $34.9M | $24.3M | $105.4M | $7.3M | $14.7M |
| EPS (diluted) | $0.12 | $0.19 | $0.70 | $0.92 | $0.66 | $2.59 | $0.20 | $0.41 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$28.9M | -$45.8M | -$13.0M | $48.8M | $192.8M |
| Capital expenditure | -$3.5M | -$11.9M | -$179.1M | -$129.7M | -$59.3M |
| Free cash flow | -$32.4M | -$57.7M | -$192.1M | -$80.9M | $133.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $1.4M | $139.9M | $7.1M | $22.9M | -$138,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $472.7M
- Total assets
- $1.46B
- Total liabilities
- $946.3M
- Total debt
- $867.7M
- Net debt
- $395.0M
- Shareholders’ equity
- $518.1M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 7,977,125
- Days to cover
- 10.68
- Change vs previous report
- -1.3%
FINRA short interest, settlement date Sep 15, 2026.